Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.
Topic:
CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Stefan Anker
Charite University Hospital, Berlin (Germany)
159
presentations
8
followers
Professor Faiez Zannad
University of Lorraine, Vandoeuvre-Les-Nancy (France)
100
presentations
4
followers
3 more presentations in this session
Why is the baroreflex a relevant target for both resistant hypertension and heart failure?
Speaker: Professor A. Pathak (Monaco, MC)
Resistant hypertension: stimulating the baroreflex when drugs have failed.
Speaker: Professor P. De Leeuw (Maastricht, NL)
Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?
Speaker: Professor C. Butter (Bernau bei Berlin, DE)
Access the full session
Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension
Speakers:
Professor S. Anker, Professor F. Zannad, Professor A. Pathak, Professor P. De Leeuw, Professor C. Butter
About the event
ESC 365 is supported by
